Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

This Review examines the state-of-the-art in the delivery of nucleic acid therapies that are directed to the vascular endothelium. First, we review the most important homeostatic functions and properties of the vascular endothelium and summarize the nucleic acid tools that are currently available for gene therapy and nucleic acid delivery. Second, we consider the opportunities available with the endothelium as a therapeutic target and the experimental models that exist to evaluate the potential of those opportunities. Finally, we review the progress to date from investigations that are directly targeting the vascular endothelium: for vascular disease, for peri-transplant therapy, for angiogenic therapies, for pulmonary endothelial disease, and for the blood-brain barrier, ending with a summary of the future outlook in this field.

Citation

Melanie Reschke, Alexandra S Piotrowski-Daspit, Jordan S Pober, W Mark Saltzman. Nucleic Acid Delivery to the Vascular Endothelium. Molecular pharmaceutics. 2022 Dec 05;19(12):4466-4486

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 36251765

View Full Text